Brief: Coherus Oncology Q2 Net Income USD -20.631 Million
05/08/2026 21:29
BRIEF-Coherus Oncology Q2 Net Income USD -20.631 Million Aug 05 (Reuters) - Coherus Oncology Q2 sales USD 14.307 million vs. IBES estimate USD 14.4 million.
- Q2 adjusted net income USD -30.139 million vs. IBES estimate USD -25.4 million
- Q2 operating income USD -32.331 million
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million